Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	8/29/2011 4:21:25 PM
	Read Replies (1) of 3027

And on this news, MNTA closed up $0.93! 11:39AM Teva Pharma; court adopts all relevant Teva claim construction interpretations in Copaxone patent case; court denies Mylan's (MYL) summary judgment motion of invalidity ( TEVA) 40.10 +0.67 : Co announced today that the U.S. District Court for the Southern District of New York has issued a favorable set of claim construction rulings in the co's patent infringement lawsuit against Sandoz (NVS)/Momenta Pharmaceuticals (MNTA) and Mylan (MYL)/Natco regarding co's multiple sclerosis product, Copaxone. The Court adopted all relevant co claim construction interpretations and rejected all of the claim construction interpretations put forth by Sandoz/Momenta and Mylan/Natco. In addition, the Court denied Mylan's motion for summary judgment that the patents at issue are invalid for indefiniteness. Teva is pleased with the Court's decision and awaits the start of a trial on September 7, 2011.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next